B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

TUBB8

MOLECULAR TARGET

tubulin beta 8 class VIII

UniProt: Q3ZCM7NCBI Gene: 3476889 compounds

TUBB8 (tubulin beta 8 class VIII) is targeted by 9 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting TUBB8

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Colchicine4.93138
2Nocodazole Nocodazole is3.3728
3Podophyllotoxin2.9418
4Vincristine2.5612
5Noscapine1.102
6Demecolcine0.691
7Maytansine0.691
8vinblastine sulfate0.691
9Vorinostat0.691

About TUBB8 as a Drug Target

TUBB8 (tubulin beta 8 class VIII) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 9 compounds with documented TUBB8 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

TUBB8 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.